MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 205 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $823 | -99.9% | 24,795 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $778,000 | +3.5% | 24,673 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $752,000 | +19.7% | 24,743 | +2.3% | 0.00% | +50.0% |
| Q1 2022 | $628,000 | +144.4% | 24,180 | +92.2% | 0.00% | +100.0% |
| Q4 2021 | $257,000 | -5.9% | 12,583 | -11.3% | 0.00% | 0.0% |
| Q3 2021 | $273,000 | -16.3% | 14,190 | -3.4% | 0.00% | -50.0% |
| Q2 2021 | $326,000 | -13.1% | 14,691 | +2.9% | 0.00% | -33.3% |
| Q1 2021 | $375,000 | +33.0% | 14,278 | -5.4% | 0.00% | +50.0% |
| Q4 2020 | $282,000 | +29.4% | 15,095 | +17.3% | 0.00% | 0.0% |
| Q3 2020 | $218,000 | -27.3% | 12,864 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $300,000 | -49.2% | 12,864 | -62.2% | 0.00% | -72.7% |
| Q4 2018 | $591,000 | +57.2% | 34,051 | +54.8% | 0.01% | -35.3% |
| Q3 2015 | $376,000 | +5.6% | 22,000 | +15.0% | 0.02% | 0.0% |
| Q2 2015 | $356,000 | – | 19,125 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 283,983 | $6,299,000 | 3.15% |
| Euclidean Technologies Management, LLC | 128,088 | $2,841,000 | 2.26% |
| GLOBEFLEX CAPITAL L P | 185,939 | $4,124,000 | 0.74% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,194,000 | 0.66% |
| CLARK ESTATES INC/NY | 220,000 | $4,880,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,424,274 | $31,590,000 | 0.56% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 789,827 | $17,518,000 | 0.53% |
| EARNEST PARTNERS LLC | 3,885,748 | $86,186,000 | 0.51% |
| MOODY ALDRICH PARTNERS LLC | 137,075 | $3,040,000 | 0.43% |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 414,323 | $9,190,000 | 0.33% |